What You Should Know:
- Mount Sinai Fuster Heart Hospital has announced the launch of The Samuel Fineman Cardiac Catheterization Artificial Intelligence (AI) Research Lab. The new AI lab will use the hospital's renowned Cardiac Catheterization Lab to advance interventional cardiology and enhance patient care and outcomes.
- Dr. Annapoorna Kini will serve as the Director of the new AI lab. She also directs The Mount Sinai Hospital’s Cardiac Catheterization Lab, which is
Read More
Cardiac Monitoring
Redefining Cardiac Outcomes Through Independent Remote Monitoring Platforms
As healthcare continues its shift toward value-based, patient-centered care, remote monitoring (RM) has become a cornerstone in the management of chronic cardiac conditions. For patients with implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy devices (CRT-Ds), real-time data collection enables earlier interventions—helping reduce hospitalizations, improve survival, and enhance quality of life.
But while the clinical value of RM is clear, its practical
Read More
Ultromics Secures $55M to Expand AI-Driven Cardiology Solutions for Heart Failure
What You Should Know:
- Ultromics, a pioneer in AI-driven cardiology solutions secures $55M in Series C financing co-led by L&G, Allegis Capital, and Lightrock, with continued support from Oxford Science Enterprises, GV, Blue Venture Fund, and Oxford University. Major U.S. health systems, including University of Chicago Medicine and UCM Ventures, also participated in the round.
- Built on years of clinical study and hundreds of thousands of echo scans, Ultromics offers the first
Read More
Cardiosense Launches Nationwide SEISMIC-HF II Study to Validate AI Algorithm for Non-Invasive Heart Failure Monitoring
What You Should Know:
- Cardiosense, a medical AI company focused on transforming cardiovascular disease management announced the launch of SEISMIC-HF II. This nationwide study aims to validate the company’s machine learning algorithm for assessing intracardiac filling pressure, an early and critical indicator of acute heart failure decompensation.
- The study marks a significant step in Cardiosense's mission to provide smarter, personalized cardiac care for all heart failure
Read More
AliveCor Unveils KardiaMobile 6L Max & KardiaAlert for Advanced Personal ECG Monitoring
What You Should Know:
- AliveCor, a leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced the launch of its most advanced personal ECG system, the AI-powered KardiaMobile® 6L Max.
- Accompanying this device is KardiaAlert™, a first-of-its-kind feature available exclusively to subscribers of AliveCor's KardiaCare service. Together, these innovations aim to provide users with more comprehensive detections and insights, monitor heart rhythms for
Read More
HeartBeam & AccurKardia Integrates Advanced ECG Analysis into Cardiac Monitoring Platform
What You Should Know:
- HeartBeam, a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced a strategic collaboration with AccurKardia, an innovator in ECG-based diagnostics technology.
- The partnership unites two innovation leaders in ambulatory electrocardiogram (ECG) recording and analysis, aiming to enhance the accessibility of advanced cardiac monitoring solutions.
Integrating Advanced ECG Analysis
Read More
Heart Failure’s Hidden Price: Understanding the True Cost of Cardiac Events and AI’s Role in Reducing Expenses
Cardiovascular disease (CVD) is a leading cause of death and a growing financial strain on the U.S. healthcare system, costing an estimated $252.2 billion annually. With one in every eight healthcare dollars spent on cardiac care, the urgency to control costs while improving patient outcomes has never been greater.
As traditional care models struggle to keep up with demand, we are faced with an important question: How can we make cardiac care more sustainable, ensuring the healthcare
Read More
HeartFlow and Boone Heart Institute Launch GAMEFILM Registry to Study Heart Health in Retired NFL Players
What You Should Know:
- HeartFlow, a global leader in AI-driven heart care solutions, and Boone Heart Institute, a renowned cardiovascular care provider in Denver, today announced the launch of the GAMEFILM Registry.
- GAMEFILM Registry will utilize advanced imaging and AI technology to assess and better understand coronary artery disease (CAD) risk in retired National Football League (NFL) players.
Understanding the Unique Cardiovascular Risks of Retired NFL
Read More
Mayo Clinic, SandboxAQ Expand Collaboration to Advance AI Cardiac Diagnostics in Amyloidosis
What You Should Know:
- Mayo Clinic is expanding its collaboration with SandboxAQ, a provider of artificial intelligence (AI) medical apps to explore the use of electrocardiography (ECG) and magnetocardiography (MCG) technologies for characterizing disease progression and treatment response in patients with amyloidosis.
- The expanded partnership highlights the potential of combining AI and advanced sensing technology to revolutionize cardiac diagnostics.
Improved Detection and
Read More
AMA Issues CPT Code for Eko Health’s AI-Powered Cardiac Screening Tool
What You Should Know:
- Eko Health, a pioneer in applying artificial intelligence for early detection of heart and lung diseases, today announced the issuance of a Category III Current Procedural Terminology (CPT) code by the American Medical Association (AMA) for its SENSORA™ platform.
-The newly issued Category III CPT code will be effective on July 1, 2025, and is the first step to coverage and reimbursement for SENSORA™, bringing advanced heart disease detection to clinicians across
Read More
